Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors. A Multicenter Phase 1b/2a Trial in Colorectal Cancer, Non-small Cell Lung Cancer, and Soft Tissue Sarcoma Patients

NCT05688280 is registered in ClinicalTrials.gov with Immunophotonics, Inc. as lead sponsor.

NCT NCT05688280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05688280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors. A Multicenter Phase 1b/2a Trial in Colorectal Cancer, Non-small Cell Lung Cancer, and Soft Tissue Sarcoma Patients
Lead sponsor
Immunophotonics, Inc.
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
November 29, 2022
Completion date
February 28, 2025
Enrollment
42 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer, metastatic solid tumor, nonsmall cell lung cancer, soft tissue sarcoma